Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces that Delia Keeling, wife of Peter Keeling, Chief Executive of Diaceutics, has transferred a total of 24,000 ordinary shares in the Company held by her to certain members of her family for nil consideration. The transfers were effected on 21 April 2020.
The following additional information is disclosed in accordance with article 19(3) of the Market Abuse Regulation.
|Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014|
|1||Details of the person discharging managerial responsibilities/person closely associated|
|2||Reason for notification|
|a.||Position/Status||Wife of Peter Keeling, Chief Executive Officer of Diaceutics plc|
|3||Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor|
|4||Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted|
|a.||Description of the financial instrument, type of instrument
|Ordinary shares of 0.2p each
|b.||Nature of the transaction||Transfer of shares to certain family members for nil consideration. The transfer comprised 1,000 shares each transferred to 24 individuals, all for nil consideration.|
|c.||Price(s) and volume(s)||Price(s) Nil
|d.||Date of the transaction||21 April 2020|
|e.||Place of the transaction||Outside a trading venue|